Literature DB >> 30391435

Time to Colonoscopy and Risk of Colorectal Cancer in Patients With Positive Results From Fecal Immunochemical Tests.

Yi-Chia Lee1, Jean Ching-Yuan Fann2, Tsung-Hsien Chiang3, Shu-Lin Chuang4, Sam Li-Sheng Chen5, Han-Mo Chiu6, Amy Ming-Fang Yen5, Sherry Yueh-Hsia Chiu7, Chen-Yang Hsu4, Wen-Feng Hsu6, Ming-Shiang Wu8, Hsiu-Hsi Chen9.   

Abstract

BACKGROUND & AIMS: In patients with positive results from a fecal immunochemical test (FIT), failure to receive a timely follow-up colonoscopy may be associated with higher risks of colorectal cancer (CRC) and advanced-stage CRC. We evaluated the prevalence of any CRC and advanced-stage CRC associated with delays in follow-up colonoscopies for patients with positive results from a FIT.
METHODS: We collected data from 39,346 patients (age, 50-69 years) who participated in the Taiwanese Nationwide Screening Program from 2004 through 2012 and had completed a colonoscopy more than 1 month after a positive result from a FIT. Risks of any CRC and advanced-stage CRC (stage III-IV) were evaluated using logistic regression models and results expressed as adjusted odds ratios (aORs) and corresponding 95% CIs.
RESULTS: In our cohort, 2003 patients received a diagnosis of any CRC and 445 patients were found to have advanced-stage disease. Compared with colonoscopy within 1-3 months (cases per 1000 patients: 50 for any CRC and 11 for advanced-stage disease), risks were significantly higher when colonoscopy was delayed by more than 6 months for any CRC (aOR, 1.31; 95% CI, 1.04-1.64; 68 cases per 1000 patients) and advanced-stage disease (aOR, 2.09; 95% CI, 1.43-3.06; 24 cases per 1000 patients). The risks continuously increased when colonoscopy was delayed by more than 12 months for any CRC (aOR, 2.17; 95% CI, 1.44-3.26; 98 cases per 1000 patients) and advanced-stage disease (aOR, 2.84; 95% CI, 1.43-5.64; 31 cases per 1000 patients). There were no significant differences for colonoscopy follow up at 3-6 months for risk of any CRC (aOR, 0.98; 95% CI, 0.86-1.12; 49 cases per 1000 patients) or advanced-stage disease (aOR, 0.95; 95% CI, 0.72-1.25; 10 cases per 1000 patients).
CONCLUSIONS: In an analysis of data from the Taiwanese Nationwide Screening Program, we found that among patients with positive results from a FIT, risks of CRC and advanced-stage disease increase with time. These findings indicate the importance of timely colonoscopy after a positive result from a FIT.
Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Colon Cancer; Endoscopy; Population; Prevention

Year:  2018        PMID: 30391435     DOI: 10.1016/j.cgh.2018.10.041

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  28 in total

1.  Operationalizing a Rideshare Intervention for Colonoscopy Completion: Barriers, Facilitators, and Process Recommendations.

Authors:  Ari Bell-Brown; Lisa Chew; Bryan J Weiner; Lisa Strate; Bryan Balmadrid; Cara C Lewis; Peggy Hannon; John M Inadomi; Scott D Ramsey; Rachel B Issaka
Journal:  Front Health Serv       Date:  2022-01-17

2.  Barriers associated with inadequate follow-up of abnormal fecal immunochemical test results in a safety-net system: A mixed-methods analysis.

Authors:  Rachel B Issaka; Ari Bell-Brown; Jason Kao; Cyndy Snyder; Dana L Atkins; Lisa D Chew; Bryan J Weiner; Lisa Strate; John M Inadomi; Scott D Ramsey
Journal:  Prev Med Rep       Date:  2022-05-18

3.  Increasing Fecal Immunochemical Test Return Rates by Implementing Effective "Reminder to Complete Kit" Communication With Participants: A Quality Improvement Study.

Authors:  Sameer Prakash; Nooraldin Merza; Omid Hosseini; Haven Ward; Tarek Mansi; Michelle Balducci; Deborah Trammell; Brenda Hernandez; Izi Obokhare
Journal:  Cureus       Date:  2022-05-20

4.  Patient randomized trial of a targeted navigation program to improve rates of follow-up colonoscopy in community health centers.

Authors:  Gloria D Coronado; Eric S Johnson; Michael C Leo; Jennifer L Schneider; David Smith; Raj Mummadi; Amanda F Petrik; Jamie H Thompson; Ricardo Jimenez
Journal:  Contemp Clin Trials       Date:  2019-12-24       Impact factor: 2.226

5.  Trends in Wait Time for Outpatient Colonoscopy in the Veterans Health Administration, 2008-2015.

Authors:  Megan A Adams; Joel H Rubenstein; Rachel Lipson; Robert G Holleman; Sameer D Saini
Journal:  J Gen Intern Med       Date:  2020-03-24       Impact factor: 5.128

6.  Time to Colonoscopy After Abnormal Stool-Based Screening and Risk for Colorectal Cancer Incidence and Mortality.

Authors:  Yazmin San Miguel; Joshua Demb; Maria Elena Martinez; Samir Gupta; Folasade P May
Journal:  Gastroenterology       Date:  2021-02-02       Impact factor: 22.682

Review 7.  Gastroenterology and liver disease during COVID-19 and in anticipation of post-COVID-19 era: Current practice and future directions.

Authors:  Katerina G Oikonomou; Panagiotis Papamichalis; Tilemachos Zafeiridis; Maria Xanthoudaki; Evangelia Papapostolou; Asimina Valsamaki; Konstantinos Bouliaris; Michail Papamichalis; Marios Karvouniaris; Panagiotis J Vlachostergios; Apostolia-Lemonia Skoura; Apostolos Komnos
Journal:  World J Clin Cases       Date:  2021-07-06       Impact factor: 1.337

8.  Precision Patient Navigation to Improve Rates of Follow-up Colonoscopy, An Individual Randomized Effectiveness Trial.

Authors:  Gloria D Coronado; Andreea M Rawlings; Amanda F Petrik; Matthew Slaughter; Eric S Johnson; Peggy A Hannon; Allison Cole; Thuy Vu; Rajasekhara R Mummadi
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-09-28       Impact factor: 4.090

Review 9.  What Multilevel Interventions Do We Need to Increase the Colorectal Cancer Screening Rate to 80%?

Authors:  John M Inadomi; Rachel B Issaka; Beverly B Green
Journal:  Clin Gastroenterol Hepatol       Date:  2019-12-27       Impact factor: 11.382

10.  COVID-19 in Gastroenterology Departments: The Impact of the First Wave.

Authors:  Tiago Leal; Margarida Gonçalves; Irina Mocanu; Rita Carvalho; Luísa Glória
Journal:  GE Port J Gastroenterol       Date:  2021-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.